Infantile acid maltase deficiency-Reference-Cited by-同舟云学术

Infantile acid maltase deficiency

Published:1984-01 Issue:1 Volume:45 Page:51-61
ISSN:0042-6431
Container-title:Virchows Archiv B Cell Pathology Including Molecular Pathology
language:en
Short-container-title:Virchows Archiv B Cell Pathol

Author:

Griffin Joe L.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/BF02889851.pdf

Reference22 articles.

1. Anderson WA (1972) Methods for electron microscopic localization of glycogen. In: Glick D, Rosenbaum RM (eds) Techniques of biochemical and biophysical morphology, vol 1. John Wiley and Sons, New York, pp 1–23

2. Bosch EP, Munsat TL (1979) Metabolic myopathies. Med Clin North Am 63:759–782

3. Canonico PG, Bird JWC (1970) Lysosomes in skeletal muscle tissue. Zonal centrifugation evidence for multiple cellular sources. J Cell Biol 45:321–333

4. Cardiff RD (1966) A histochemical and electron microscopic study of skeletal muscle in a case of Pompe’s disease (Glycogenosis II). Pediatrics 37:249–259

5. Engel AG (1970) Acid maltase deficiency in adults: Studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain 93:599–616

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outside the fiber: Endomysial stromal and capillary pathology in skeletal muscle may impede infusion therapy in infantile-onset Pompe disease;Journal of Neuropathology & Experimental Neurology;2023-03-02

2. DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery;Frontiers in Cell and Developmental Biology;2019-12-06

3. The respiratory neuromuscular system in Pompe disease;Respiratory Physiology & Neurobiology;2013-11

4. Reversal of Cardiac Dysfunction after Enzyme Replacement in Patients with Infantile-Onset Pompe Disease;The Journal of Pediatrics;2009-08

5. Therapeutic approaches in glycogen storage disease type II/pompe disease;Neurotherapeutics;2008-10